AU2003277608A1 - Drugs comprising combination of elastase inhibitor with blood coagulation system and/or fibrinolysis system enzyme inhibitor - Google Patents
Drugs comprising combination of elastase inhibitor with blood coagulation system and/or fibrinolysis system enzyme inhibitorInfo
- Publication number
- AU2003277608A1 AU2003277608A1 AU2003277608A AU2003277608A AU2003277608A1 AU 2003277608 A1 AU2003277608 A1 AU 2003277608A1 AU 2003277608 A AU2003277608 A AU 2003277608A AU 2003277608 A AU2003277608 A AU 2003277608A AU 2003277608 A1 AU2003277608 A1 AU 2003277608A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitor
- drugs
- combination
- blood coagulation
- fibrinolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940122858 Elastase inhibitor Drugs 0.000 title 1
- 230000023555 blood coagulation Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003602 elastase inhibitor Substances 0.000 title 1
- 239000002532 enzyme inhibitor Substances 0.000 title 1
- 229940125532 enzyme inhibitor Drugs 0.000 title 1
- 230000020764 fibrinolysis Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002324646A JP2006096668A (en) | 2002-11-08 | 2002-11-08 | Medicine comprising combination of elastase inhibitor with enzyme inhibitor of blood coagulation system and/or fibrinolysis system |
| JP2002-324646 | 2002-11-08 | ||
| PCT/JP2003/014198 WO2004041309A1 (en) | 2002-11-08 | 2003-11-07 | Drugs comprising combination of elastase inhibitor with blood coagulation system and/or fibrinolysis system enzyme inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003277608A1 true AU2003277608A1 (en) | 2004-06-07 |
Family
ID=32310453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003277608A Abandoned AU2003277608A1 (en) | 2002-11-08 | 2003-11-07 | Drugs comprising combination of elastase inhibitor with blood coagulation system and/or fibrinolysis system enzyme inhibitor |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2006096668A (en) |
| AU (1) | AU2003277608A1 (en) |
| WO (1) | WO2004041309A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2445920A (en) * | 2007-01-25 | 2008-07-30 | Mucokinetica Ltd | Amidino compounds for treatment of respiratory disease |
| RU2354361C1 (en) * | 2007-08-08 | 2009-05-10 | Государственное образовательное учреждение высшего профессионального образования Тюменская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО ТюмГМА Росздрава) | Method of preventing complications in hysteromyoma in case of hysterectomy |
| JP2013014550A (en) * | 2011-07-05 | 2013-01-24 | Kao Corp | Aggrecan degradation inhibitor |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE757496A (en) * | 1969-10-14 | 1971-03-16 | Ono Pharmaceutical Co | NEW PHENYL ESTERS OF GUANIDINOCAPROIC ACID AND THEIR PRODUCTION |
| IE48623B1 (en) * | 1978-08-31 | 1985-03-20 | Mitsubishi Chem Ind | Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances |
| CA1136620A (en) * | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
| FR2482611B1 (en) * | 1980-05-14 | 1986-03-07 | Pharmindustrie | NOVEL SULFATED POLYSACCHARIDES, METHODS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| AU527371B2 (en) * | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
| US4818816A (en) * | 1981-04-28 | 1989-04-04 | Choay, S.A. | Process for the organic synthesis of oligosaccharides and derivatives thereof |
| ATE15142T1 (en) * | 1981-05-21 | 1985-09-15 | Akzo Nv | ANTITHROMBOTICAL BASED ON POLYSACCHARIDS, PROCESS FOR ITS PRODUCTION AND MEDICINAL COMPOSITIONS. |
| DE58903988D1 (en) * | 1985-04-11 | 1993-05-13 | Hoechst Ag | HIRUDINE DERIVATIVE. |
| EP0816494A1 (en) * | 1987-01-08 | 1998-01-07 | Asahi Kasei Kogyo Kabushiki Kaisha | DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same |
| CA1340191C (en) * | 1988-06-13 | 1998-12-15 | Katsuhiro Imaki | Derivatives of p-substituted phenyl ester of pivalic acid |
| US5202421A (en) * | 1988-12-27 | 1993-04-13 | Mochida Pharmaceutical Co., Ltd. | Anticoagulant substance obtained from urine and process for the preparation thereof |
| CA2255396A1 (en) * | 1990-11-08 | 1992-05-09 | Nippon Mining Company Limited | Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing said vector and manufacturing method ofproducts which is produced from said microorganism |
| ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| ATE307596T1 (en) * | 1997-05-27 | 2005-11-15 | Sanofi Aventis | USE OF AN OLIGOSACCHARIDE TO PREVENT BLOOD CLOTTING IN EXTRACORPORAL CIRCUITS |
| KR20030016214A (en) * | 2000-01-06 | 2003-02-26 | 일라이 릴리 앤드 캄파니 | Combination Therapy for the Treatment of Inflammatory and Respiratory Diseases |
-
2002
- 2002-11-08 JP JP2002324646A patent/JP2006096668A/en active Pending
-
2003
- 2003-11-07 WO PCT/JP2003/014198 patent/WO2004041309A1/en not_active Ceased
- 2003-11-07 AU AU2003277608A patent/AU2003277608A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004041309A1 (en) | 2004-05-21 |
| JP2006096668A (en) | 2006-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002243879A1 (en) | Integrated blood handling system having active gas removal system and methods of use | |
| AP2004003035A0 (en) | Inhibitors of factor xa and other serine proteasesinvolved in the coagulation cascade. | |
| AU2003303597A1 (en) | Continuous glucose monitoring system and methods of use | |
| EP1539275A4 (en) | Blood aspiration system and methods of use | |
| AU2003299817A1 (en) | Genetic polymorphisms associated with stenosis, methods of detection and uses thereof | |
| AU1853600A (en) | Method for the detection of gene transcripts in blood and uses thereof | |
| AU2002233643A1 (en) | Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases | |
| AU2003241347A1 (en) | Medical catheter assembly and method of using the same | |
| AU2003251567A1 (en) | Dialysis system for treatment of vulnerable patients and methods of use | |
| AU2003226027A1 (en) | System for performing blood coagulation assays and measuring blood clotting times | |
| EP1571970A3 (en) | Diagnosis and monitoring of diseases | |
| AU2003281712A1 (en) | Rotation system with three degree of freedom and application of the same | |
| EP1482033A4 (en) | ENZYME GENE OF CELLULOSE DIGESTION AND USE THEREOF | |
| AU2001249389A1 (en) | Modified blood clotting factors and methods of use | |
| AU2003235956A1 (en) | Quinazoline derivative and medicine | |
| AU2002303261A1 (en) | Gene brcc2 and diagnostic and therapeutic uses thereof | |
| AU2002366501A1 (en) | Method of detection and enumeration of bacteria | |
| AU2003277608A1 (en) | Drugs comprising combination of elastase inhibitor with blood coagulation system and/or fibrinolysis system enzyme inhibitor | |
| AU2003226496A1 (en) | Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids | |
| AU2003290663A1 (en) | Assay for tissue factor and factor viia | |
| AU2002343042A1 (en) | Virulence proteins of the genus yersinia and uses thereof | |
| AU2003237870A1 (en) | Method and composition for inhibing or slowing blood coagulation | |
| AU2003239469A1 (en) | Systems and methods of ph tissue monitoring | |
| AU2003282747A1 (en) | ISOTHERMAL AMPLIFICATION BASED ASSAY FOR THE DETECTION AND QUANTITATION OF ALPHA-FETOPROTEIN mRNA | |
| AU2003285217A1 (en) | Variants of phosphotriesterases with enhanced and/or altered substrate specificity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |